PCIDB

KNApSAcK Metabolite C00001755

Metabolite

KNApSAcK Entry

id C00001755
Name Olivacine
CAS RN 484-49-1
Standard InChI InChI=1S/C17H14N2O/c1-10-13-9-14-11-5-3-4-6-15(11)19-16(14)17(20-2)12(13)7-8-18-10/h3-9,19H,1-2H3
Standard InChI (Main Layer) InChI=1S/C17H14N2O/c1-10-13-9-14-11-5-3-4-6-15(11)19-16(14)17(20-2)12(13)7-8-18-10/h3-9,19H,1-2H3

Cluster

Phytochemical cluster No. 4
KCF-S cluster No. 1510

Link

ChEMBL

By standard InChI
By standard InChI Main Layer

KEGG

By LinkDB C09230

CTD

By CAS RN C011521

Human Protein / Gene in interaction

CTD interaction (6)

compound gene gene name gene description interaction interaction type form reference
pmid
C011521 196 AHR
bHLHe76
aryl hydrocarbon receptor [olivacine analog co-treated with Tetrachlorodibenzodioxin] results in increased activity of AHR protein affects cotreatment
/ increases activity
protein 14709624
C011521 196 AHR
bHLHe76
aryl hydrocarbon receptor olivacine analog results in increased activity of AHR protein increases activity
protein 14709624
C011521 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) CYP1A1 protein affects the metabolism of olivacine analog affects metabolic processing
protein 14709624
C011521 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) CYP1A2 protein affects the metabolism of olivacine analog affects metabolic processing
protein 14709624
C011521 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) olivacine analog results in increased expression of and results in increased activity of CYP1A2 protein increases activity
/ increases expression
protein 14709624
C011521 2328 FMO3
FMOII
TMAU
dJ127D3.1
flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148) FMO3 protein affects the metabolism of olivacine analog affects metabolic processing
protein 14709624